Log in to search using one of your social media accounts:

 

Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials

Publication date: Available online 5 December 2017 Source:The Lancet Author(s): Martin R Gaudinski, Katherine V Houser, Kaitlyn M Morabito, Zonghui Hu, Galina Yamshchikov, Ro Shauna Rothwell, Nina Berkowitz, Floreliz Mendoza, Jamie G Saunders, Laura Novik, Cynthia S Hendel, LaSonji A Holman, Ingelise J Gordon, Josephine H Cox, Srilatha Edupuganti, Monica A McArthur, Nadine G Rouphael, Kirsten E Lyke, Ginny E Cummings, Sandra Sitar, Robert T Bailer, Bryant M Foreman, Katherine Burgomaster, Rebecca S Pelc, David N Gordon, Christina R DeMaso, Kimberly A Dowd, Carolyn Laurencot, Richard M Schwartz, John R Mascola, Barney S Graham, Theodore C Pierson, Julie E Ledgerwood, Grace L Chen Background The Zika virus epidemic and associated congenital infections have prompted rapid vaccine development. We assessed two new DNA vaccines expressing premembrane and envelope Zika virus structural proteins. Methods We did two phase 1, randomised, open-label trials involving healthy adult volunteers. The VRC 319 trial, done in three centres, assessed plasmid VRC5288 (Zika virus and Japanese encephalitis virus chimera), and the VRC 320, done in one centre, assessed plasmid VRC5283 (wild-type Zika virus). Eligible participants were aged 18–35 years in VRC19 and 18–50 years in VRC 320. Participants were randomly assigned 1:1 by a computer-generated randomisation schedule prepared by the study statistician. All participants received intramuscular injection of 4 mg vaccine. In VRC 319 pa...
Source: The Lancet - Category: General Medicine Source Type: research

Related Links:

Source: BMJ Comments - Category: General Medicine Source Type: forums
Authors: Ficke JR, Moroski NM, Ross SD, Gupta R Abstract Patients often seek nontraditional forms of treatment, including alternative/complementary medical options, such as chiropractic care and acupuncture, to meet their personal needs. In the United States, interest has grown in methods to reduce pain and improve function through Ayurvedic medicine, which uses plant-based supplements, such as turmeric. Traditional allopathic medicine attempts to provide patients with evidence-based therapeutic regimens for their musculoskeletal conditions. Integrative medicine often is used to prevent and manage the sequelae asso...
Source: The Journal of the American Academy of Orthopaedic Surgeons - Category: Orthopaedics Tags: J Am Acad Orthop Surg Source Type: research
HEARTBURN symptoms include nausea and difficulty swallowing. Combat the pain while sleeping by making these changes to your diet.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
Abstract Beginning in 2004, chikungunya virus (CHIKV) went from an endemic pathogen limited to Africa and Asia that caused periodic outbreaks to a global pathogen. Given that outbreaks caused by CHIKV have continued and expanded, serious consideration must be given to identifying potential options for vaccines and therapeutics. Currently, there are no licensed products in this realm, and control relies completely on the use of personal protective measures and integrated vector control, which are only minimally effective. Therefore, it is prudent to urgently examine further possibilities for control. Vaccines have ...
Source: Clinical Microbiology Reviews - Category: Microbiology Authors: Tags: Clin Microbiol Rev Source Type: research
Most children born with Zika-related microcephaly will have severe motor impairment and other functional and medical difficulties as they age, according to an analysis...
Source: Physician's First Watch current issue - Category: Primary Care Source Type: news
Authors: Sheerin I Abstract New Zealand and Australia both now have the potential for a major public health success in controlling the hepatitis C virus epidemic. The burden of advanced liver disease and drug-related harm is increasing. However, a new range of anti-viral therapies have become available which offer a potential cure for most people with few side-effects. The epidemic is potentially preventable and hepatitis C is now curable. Although public health strategies for blood-borne viruses have been updated, they fall short of what is needed and should be upgraded with more emphasis on prevention, in order t...
Source: New Zealand Medical Journal - Category: General Medicine Tags: N Z Med J Source Type: research
CONCLUSION: Time to diagnosis of CN was shorter than previously reported, though the high rate of deformities still suggests a significant delay in diagnosis. Increased education of healthcare professionals and people with diabetes-related neuropathy is important to ensure early diagnosis and appropriate management to reduce deformities and complications. PMID: 29240741 [PubMed - in process]
Source: New Zealand Medical Journal - Category: General Medicine Tags: N Z Med J Source Type: research
CONCLUSION: Use of MRI can aid in the early diagnosis and facilitate faster rehabilitation for patients. It can also potentially reduce patient stay in hospital and result in significant cost savings for the healthcare system. Imaging guidelines should be developed in the assessment of patients with low back pain in an acute hospital setting. PMID: 29240738 [PubMed - in process]
Source: New Zealand Medical Journal - Category: General Medicine Tags: N Z Med J Source Type: research
There is a great unmet need for effective and tolerable treatments for migraine. This primary headache disorder is the leading cause of neurological disability worldwide and is one of the five leading causes of long-term disability.1 The success of available antimigraine treatments is limited by inadequate effectiveness, adverse effects, and poor patient adherence. Furthermore, the drugs available for prophylaxis are not specific for migraine, but include antiepileptic drugs, β-blockers, and antidepressants.
Source: Lancet Neurology - Category: Neurology Authors: Tags: 2017 Round-up Source Type: research
The opioid crisis has attracted increasing commentary during 2017. A recent study has shown that after surgery, in the USA, one in 16 patients will become a chronic opioid user.1 This number does not differ when comparing minor versus major surgery and largely represents inappropriate use of opioid analgesics triggered by overprescribing. This problem emphasises the need to optimise health-care delivery and to develop new, effective, and non-addictive drugs for the treatment of chronic pain.
Source: Lancet Neurology - Category: Neurology Authors: Tags: 2017 Round-up Source Type: research
More News: Allergy | Allergy & Immunology | Clinical Trials | Computers | Encephalitis | Epidemics | Epidemiology | Funding | General Medicine | Headache | Infectious Diseases | Japan Health | Men | Migraine | National Institutes of Health (NIH) | Pain | Statistics | Study | Vaccines | Zika Virus